Peculiarities of community-acquired pneumonia in tobacco-smoking patients

T. Shchukina, V. Trofimov (Saint-Petersburg, Russian Federation)

Source: Annual Congress 2009 - Tobacco: from smoke to disease
Session: Tobacco: from smoke to disease
Session type: Thematic Poster Session
Number: 1168
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Shchukina, V. Trofimov (Saint-Petersburg, Russian Federation). Peculiarities of community-acquired pneumonia in tobacco-smoking patients. Eur Respir J 2009; 34: Suppl. 53, 1168

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Particularities of community-acquired pneumonia in the elderly
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007


Etiology and clinical outcome of community-acquired pneumonias in hospitalized children
Source: Eur Respir J 2007; 30: Suppl. 51, 398s
Year: 2007

Etiological spectrum of hospitalized community-acquired pneumonia
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


The tobacco-smoking influence on the community-acquired pneumonia course
Source: Eur Respir J 2006; 28: Suppl. 50, 247s
Year: 2006

Mixed community-acquired pneumonia in hospitalised patients
Source: Eur Respir J 2006; 27: 795-800
Year: 2006



The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010


Management of community-acquired pneumonia in adult outpatients
Source: Eur Respir J 2006; 28: Suppl. 50, 377s
Year: 2006

Preventing community-acquired pneumonia
Source: International Congress 2019 – Respiratory infections: prevention is better than cure
Year: 2019


Ethyology of community-acquired pneumonia in servicemen at the age of 18–21
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012

Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Update on community-acquired pneumonia
Source: International Congress 2017 – ME5 Update on community-acquired pneumonia
Year: 2017


Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 106s
Year: 2006

Severe community-acquired pneumonia
Source: Eur Respir Monogr 2016; 74: 101-116
Year: 2016


Bacteraemia in outpatients with community-acquired pneumonia
Source: Eur Respir J 2016; 47: 654-657
Year: 2016


Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Etiology and antibiotic resistance patterns in adults with severe community-acquired pneumonia in Russia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010